Eterna Therapeutics (ERNA) Fails to deliver data

Key failure to deliver metrics for Eterna Therapeutics:

• Last SEC data release: 2026-06-30
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: NZ$0.01 M
• Last 12 months FTD volume: NZ$4.71 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Eterna Therapeutics (ERNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Eterna Therapeutics (ERNA) - since 2025

Eterna Therapeutics (ERNA) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Sanofi SNY	NZ$6.03 M	NZ$23.87 M	🇫🇷 France
Baxter BAX	NZ$20.98 M	NZ$0.11 B	🇺🇸 USA
Omeros Corporation OMER	NZ$23.92 M	NZ$39.6 M	🇺🇸 USA
Geron GERN	NZ$0.2 M	NZ$6.03 M	🇺🇸 USA
Genetic Technologies GENE	N/A	NZ$0 M	🇦🇺 Australia
Teva Pharmaceutical Industries TEVA	NZ$5.85 M	NZ$80.51 M	🇮🇱 Israel
Bio-Techne TECH	NZ$0.11 B	NZ$0.13 B	🇺🇸 USA